Company / Book Value per Share
Oric Pharmaceuticals, Inc. Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$4.378
FY2025
5-year range
$3.487 / $7.192
FY2021-FY2025
Trend
+25.6%
vs FY2024
Sector context
#112 of 209
Health Care
What the data says
At $4.378, Oric Pharmaceuticals, Inc.'s book value per share ranks #112 of 209 in the Health Care sector. Book Value per Share returned to growth in FY2025 after 4 years of decline, reaching $4.378.
Based on SEC 10-K filings.
$4.378 in FY2025 with a 5-year CAGR of -19.8%.
Remained stable around $4.378 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -7.9%
- 5-Year CAGR
- -19.8%
- 10-Year CAGR
- -
Sector benchmark
#112 of 209 in Health CareTop 54% of 209This company $4.378 Sector average $189.406
▼
-97.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -19.8%, indicating a declining trend.
- In FY2025, book value per share increased 25.6% year-over-year.
- Ranks #112 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.378 | +25.6% |
| FY2024 | $3.487 | -19.9% |
| FY2023 | $4.355 | -22.3% |
| FY2022 | $5.607 | -22.0% |
| FY2021 | $7.192 | -45.5% |
| FY2020 | $13.206 | +127.8% |
| FY2019 | -$47.429 | -27.7% |
| FY2018 | -$37.152 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026